Conversely, an elevation of PGRN has been shown to be protective ... including frontotemporal dementia, Alzheimer’s disease, Parkinson's disease, and Lewy body dementia. The company is also ...
BTIG analyst Thomas Shrader maintained a Buy rating on Alector (ALEC – Research Report) today and set a price target of $5.00.Invest with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback